Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05548517 · ClinicalTrials.gov registry record · NA

TRE: Microbiome, Metabolic Health and Bone

A NA study of Weight Loss and Bone Loss, sponsored by Rutgers, The State University of New Jersey.

Active
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT05548517 is a NA study of Weight Loss and Bone Loss that is active but no longer recruiting, run by Rutgers, The State University of New Jersey. The registered enrollment target is 48 participants, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05548517, a NA study of Weight Loss and Bone Loss, is active but no longer recruiting, sponsored by Rutgers, The State University of New Jersey.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

In the Time-Restricted Eating: Microbiome and Bone (TREMBO) study, the primary goal is to determine the effect of time-restricted eating with caloric restriction compared to caloric restriction alone on body weight, the gut microbiota, and bone health in older women who are overweight or obese.

Interventions

  • BEHAVIORAL Calorie Restriction
  • BEHAVIORAL Time Restricted Eating (TRE)

Study Locations (1)

New Jersey

  • Rutgers University - NJ Inst Food Nutrition & Health - New Brunswick

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2022-10-15
Est. Completion 2025-07-01
Phase NA

What the Registry Record Tells You About NCT05548517

The ClinicalTrials.gov registry entry for NCT05548517 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (97% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Weight Loss appearing as the primary indexed condition, and to 2 interventions - of which Calorie Restriction is the first listed.

NCT05548517 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT05548517 about?

NCT05548517 is a clinical study titled "TRE: Microbiome, Metabolic Health and Bone". In the Time-Restricted Eating: Microbiome and Bone (TREMBO) study, the primary goal is to determine the effect of time-restricted eating with caloric restriction compared to caloric restriction alone on body weight, the gut microbiota, and bone health in older women who are overweight or obese.

What is the current status of trial NCT05548517?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2022-10-15. Estimated completion is 2025-07-01.

What conditions does trial NCT05548517 study?

This clinical trial studies the following conditions: Weight Loss, Bone Loss, Time Restricted Feeding.

What interventions are being tested in trial NCT05548517?

The interventions under investigation include: Calorie Restriction (BEHAVIORAL), Time Restricted Eating (TRE) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05548517?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05548517 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Weight Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.